Free tool
Stocks near their 52-week high
We cover 17 companies trading within 5% of their own 52-week high. The median market value in the group is $7.01B. Across the group, the median move over the past trading day is +1.08%. Price change over the past year runs from +12.3% to +74.6% across the middle 80 percent of the group, with a median of +32.3%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
17 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +73.55% |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +32.34% |
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% |
| RHO.DE | Roche Holding AG | $370.84B | Mega cap | +41.42% |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% |
| DEMANT.CO | Demant A/S | $9.36B | Mid cap | +17.12% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +1.26% |
| BBZA.DE | BB Biotech AG | $3.87B | Mid cap | +7.22% |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +15.65% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| INIFY.OL | INIFY Laboratories AB | $81.09M | Micro cap | +44.55% |
| SAR.L | Sareum Holdings plc | $70.10M | Micro cap | +76.19% |
| OHGR.L | One Health Group Plc | $53.82M | Micro cap | +17.03% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.